Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
Part of this work has been presented at ESMO annual meeting in Madrid, Spain in October 2023 (Poster 1336 P).
Authors
- Gernot G. U. Rohde (ORCID: https://orcid.org/0000-0002-5193-7755)
- Maximilian J. Hochmair (ORCID: https://orcid.org/0000-0002-8673-2450)
- Anna Klimová (ORCID: https://orcid.org/0000-0002-8745-8617)
- David König (ORCID: https://orcid.org/0000-0003-3559-6855)
- Christoph Schubart (ORCID: https://orcid.org/0000-0003-0084-9330)
- Albrecht Stenzinger (ORCID: https://orcid.org/0000-0003-1001-103X)
- Tobias Raphael Overbeck (ORCID: https://orcid.org/0000-0002-2579-0171)
- Ioannis Athanasios Vathiotis (ORCID: https://orcid.org/0000-0002-1772-5986)
- Martin Wermke (ORCID: https://orcid.org/0000-0002-4844-4087)
- Carina Wenzel (ORCID: https://orcid.org/0000-0001-5869-6934)
- Sebastian Yves Friedrich Michels (ORCID: https://orcid.org/0000-0003-3164-870X)
- Daniela Ellen Aust (ORCID: https://orcid.org/0000-0002-4867-8852)
- Frank Griesinger (ORCID: https://orcid.org/0000-0002-6822-5498)
- Xuefu Wang (ORCID: https://orcid.org/0000-0001-7212-7156)
- Korinna Jöhrens (ORCID: https://orcid.org/0000-0001-5934-544X)
- Rajwanth R. Veluswamy (ORCID: https://orcid.org/0000-0001-7323-210X)
- Natalie Pelusi (ORCID: https://orcid.org/0009-0004-9305-2762)
- Felix Carl Saalfeld (ORCID: https://orcid.org/0000-0002-4095-8649)
- Oliver Illini (ORCID: https://orcid.org/0000-0002-7322-7092)
- Marcel Wiesweg (ORCID: https://orcid.org/0000-0002-9698-9559)
- Claas Wesseler (ORCID: https://orcid.org/0000-0002-9261-7504)
- Anna Rasokat (ORCID: https://orcid.org/0009-0008-7850-6374)
- Jürgen Alt
- Diego Kauffmann‐Guerrero (ORCID: https://orcid.org/0000-0003-1471-3290)
- Petros Christopoulos (ORCID: https://orcid.org/0000-0002-7966-8980)
- Konstantinos N. Syrigos
- Michael Allgäuer (ORCID: https://orcid.org/0000-0003-4518-7887)
- Jörg Möller
- Jutta Kirfel (ORCID: https://orcid.org/0000-0003-2740-7700)
- Maret Schütz
- Jonas Kulhavy (ORCID: https://orcid.org/0000-0002-8837-1687)
- Christian Grohé (ORCID: https://orcid.org/0000-0003-2724-7647)
Institutions
- Goethe University Frankfurt (DE)
- University of Bonn (DE)
- German Cancer Research Center (DE)
- University of Cologne (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Johannes Gutenberg University Mainz (DE)
- National and Kapodistrian University of Athens (GR)
- Heidelberg University (DE)
- University Hospital Bonn (DE)
- University Hospital Heidelberg (DE)
- University Hospital of Basel (CH)
- Universitätsklinikum Erlangen (DE)
- Düsseldorf University Hospital (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Universitäres Kinderwunschzentrum Lübeck (DE)
- Comprehensive Cancer Center Mainfranken (DE)
- National Center for Tumor Diseases (DE)
- University Hospital Schleswig-Holstein (DE)
- Universitätsmedizin Göttingen (DE)
- Kantonsspital Baden (CH)
- Pius Hospital Oldenburg (DE)
- Universitätsklinikum Würzburg (DE)
- German Center for Lung Research (DE)
- University Hospital Frankfurt (DE)
- Asklepios Klinikum Harburg (DE)
- Comprehensive Cancer Center Erlangen (DE)
- University Hospital Cologne (DE)
- Karl Landsteiner Society (AT)
- University Hospital Carl Gustav Carus (DE)
- Klinikum Chemnitz (DE)
- Institut für Lungenforschung (DE)
- Heinrich Heine University Düsseldorf (DE)
- Technische Universität Dresden (DE)
- Ludwig-Maximilians-Universität München (DE)
- University of Lübeck (DE)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2024-10-12
- DOI
- https://doi.org/10.1016/j.ejca.2024.115065
- Citations
- 18
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.09
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Ariad Pharmaceuticals
- Celgene
- Regeneron Pharmaceuticals
- Novocure
- Les Laboratories Pierre Fabre
- BeiGene
- Incyte
- Seagen
- Insmed
- Bundesamt für Gesundheit
- Daiichi-Sankyo
- Eisai
- Astellas Pharma
- Deutsche Krebshilfe
- Servier
- Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung
- PharmaMar
- Grifols
- Geistlich Pharma
- EMD Serono
- Chugai Pharmaceutical
- Daiichi Sankyo Europe
- Cilag